Goldhirsh-Yellin Foundation Partners with NETRF to Advance NET Research
NETRF is proud to announce a two-year, $1 million grant from the Goldhirsh-Yellin Foundation. This significant gift will support research into the cause and treatment of neuroendocrine tumors. "We are pleased to donate to NETRF to support promising research focusing on the understanding of NETs," said Susan Grinel, PhD, Philanthropy Advisor for the Goldhirsh-Yellin Foundation.
The new grant will make it possible to advance our understanding of intestinal neuroendocrine tumors. “We are excited to have the Goldhirsh-Yellin Foundation as a long-standing partner in the search for cures for neuroendocrine cancer,” said Elyse Gellerman, NETRF CEO. It is through the generosity of this foundation and other major donors that NETRF can fund innovative research leading us to better treatments and ultimately cures for NETs.”